Niki BioSolutions (NIKI)
Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commerc...
- Open
- 7.150
- High
- 9.680
- Low
- 6.050
- Prev. Close
- 6.510
- Volume
- 4.14M
- Turnover
- 34.70M
- Avg Price
- 8.391
- Bid/Ask Ratio
- --
- Amplitude
- 55.76%
- 52wk High
- 12.240
- Volume Ratio
- 6.28
- Turnover Ratio
- 771.58%
Niki BioSolutions Analyst Rating
View moreForecast & Rating
May 6, 2023Price forecast
$1500.0024093.55%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 55 minutes ago
Credit and Gold Proxies Highlight Shifting Rate Expectations in 2026
- TradingView · 13 hours ago
Ian Huen named CEO and Alidad Mireskandari named COO of Niki BioSolutions
- PUBT · Aug 21 at 09:18 PM
Aptorum files amended 8-K updating DiamiR Biosciences financial statements
- TradingView · Jul 24 at 08:36 PM
Kira Sheinerman Secures Board Rights at Niki BioSolutions with 51.56% Stake
- US Stock Market Update · Jul 23 at 07:10 PM
Niki BioSolutions falls 9% as gains fade after gene testing deal
